Chembio Diagnostics Profit Margin 2006-2020 | CEMI
Current and historical gross margin, operating margin and net profit margin for Chembio Diagnostics (CEMI) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Chembio Diagnostics net profit margin as of March 31, 2020 is -48.02%.
| Chembio Diagnostics Annual Profit Margins |
|---|
| Chembio Diagnostics Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.089B | $0.034B |
| CHEMBIO DIAGNOSTICS, INC. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $5 billion point-of-care testing market. Chembio's two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by a third party company. Chembio markets its HIV STAT-PAK line of rapid HIV tests internationally to government and donor-funded programs directly and through distributors. Chembio also has rapid tests for veterinary tuberculosis and chagas disease. In 2007 Chembio received a U.S. patent for its Dual Path Platform technology which has significant advantages over lateral-flow technologies. This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products based on DPP. Chembio is licensed by the U.S. Food and Drug Administration as well as the U. S. Department of Agriculture, and is certified for the global market under the International Standards Organization directive 13.485. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $165.688B | 28.73 |
| Medtronic (MDT) | Ireland | $120.891B | 19.64 |
| Stryker (SYK) | United States | $66.633B | 21.63 |
| Boston Scientific (BSX) | United States | $48.278B | 22.70 |
| Baxter (BAX) | United States | $43.462B | 26.53 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.008B | 0.00 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $28.981B | 0.00 |
| Terumo (TRUMY) | Japan | $28.231B | 36.09 |
| ResMed (RMD) | United States | $28.021B | 44.22 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.281B | 15.28 |
| Sunny Optical Technology (SNPTF) | China | $20.840B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.828B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $14.172B | 64.51 |
| Insulet (PODD) | United States | $13.329B | 1320.56 |
| DiaSorin S.p.A (DSRLF) | Italy | $11.312B | 0.00 |
| Quidel (QDEL) | United States | $10.288B | 80.85 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $8.773B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $7.676B | 39.13 |
| Perrigo (PRGO) | Ireland | $7.396B | 13.23 |
| Hill-Rom Holdings (HRC) | United States | $7.394B | 20.84 |
| William Demant Holdings (WILYY) | Denmark | $6.296B | 0.00 |
| Canopy Growth (CGC) | Canada | $5.620B | 0.00 |
| Haemonetics (HAE) | United States | $4.381B | 26.31 |
| Neogen (NEOG) | United States | $4.079B | 69.10 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.977B | 0.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.923B | 0.00 |
| ICU Medical (ICUI) | United States | $3.761B | 27.44 |
| Agios Pharmaceuticals (AGIO) | United States | $3.676B | 0.00 |
| Envista Holdings (NVST) | United States | $3.138B | 0.00 |
| NuVasive (NUVA) | United States | $2.743B | 22.03 |
| TG Therapeutics (TGTX) | United States | $2.661B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.237B | 38.71 |
| AtriCure (ATRC) | United States | $1.768B | 0.00 |
| MacroGenics (MGNX) | United States | $1.508B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.361B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $1.333B | 0.00 |
| Aphria (APHA) | Canada | $1.206B | 0.00 |
| Cerus (CERS) | United States | $1.148B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $1.069B | 40.24 |
| Cardiovascular Systems (CSII) | United States | $1.042B | 0.00 |
| Vapotherm (VAPO) | United States | $1.014B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 19.85 |
| PetIQ (PETQ) | United States | $0.961B | 27.75 |
| DFB Healthcare Acquisitions (AHCO) | United States | $0.890B | 148.08 |
| OraSure Technologies (OSUR) | United States | $0.860B | 173.13 |
| Zynex (ZYXI) | United States | $0.853B | 85.70 |
| InMode (INMD) | Israel | $0.853B | 18.02 |
| Quanterix (QTRX) | United States | $0.779B | 0.00 |
| Omeros (OMER) | United States | $0.731B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.646B | 46.29 |
| BioLife Solutions (BLFS) | United States | $0.572B | 162.82 |
| VAREX IMAGING (VREX) | United States | $0.571B | 14.18 |
| Lantheus Holdings (LNTH) | United States | $0.571B | 11.49 |
| Surmodics (SRDX) | United States | $0.562B | 67.75 |
| LeMaitre Vascular (LMAT) | United States | $0.521B | 29.67 |
| Owens & Minor (OMI) | United States | $0.466B | 12.33 |
| Viemed Healthcare (VMD) | United States | $0.413B | 36.62 |
| Cytosorbents (CTSO) | United States | $0.368B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.343B | 0.00 |
| HEXO (HEXO) | $0.328B | 0.00 | |
| Utah Medical Products (UTMD) | United States | $0.302B | 21.90 |
| Organigram Holdings (OGI) | Canada | $0.262B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.224B | 124.11 |
| Female Health (VERU) | United States | $0.209B | 0.00 |
| Chimerix (CMRX) | United States | $0.192B | 0.00 |
| Surface Oncology (SURF) | United States | $0.161B | 0.00 |
| Bovie Medical (APYX) | United States | $0.158B | 0.00 |
| Fonar (FONR) | United States | $0.134B | 11.83 |
| Exagen (XGN) | United States | $0.133B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.122B | 0.00 |
| United Health Products (UEEC) | United States | $0.117B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.114B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.108B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.104B | 0.00 |
| Evolus (EOLS) | United States | $0.102B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.080B | 0.00 |
| Nephros (NEPH) | United States | $0.068B | 0.00 |
| United-Guardian (UG) | United States | $0.066B | 15.32 |
| Capricor Therapeutics (CAPR) | United States | $0.065B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.063B | 0.00 |
| Brainsway (BWAY) | Israel | $0.060B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.036B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.027B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.021B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.017B | 0.00 |
| Myomo (MYO) | United States | $0.010B | 0.00 |
| Conatus Pharmaceuticals (HSTO) | United States | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.005B | 0.00 |
